Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property February 26, 2021
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression February 21, 2021
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder February 18, 2021
Single, Fixed-Dose Intranasal Ketamine for Alleviation of Acute Suicidal Ideation. An Emergency Department, Trans-Diagnostic Approach: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial February 14, 2021
What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review February 11, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research February 3, 2021
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine January 25, 2021
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression January 22, 2021
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression January 22, 2021
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants January 20, 2021
